Skip to content
  • 6,812 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Special notice

RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)

RRPV-RPP-26-10-RAPID

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Response deadline

May 13, 2026 at 1:00 PM EDT

Closed 172 days ago. Posted April 15, 2026. Scheduled to archive May 28, 2026.

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one closed in 2026

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority  (BARDA) entitiled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)".

Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use. The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats, with the goal of significantly compressing development timelines from pathogen sequence to assay-ready reagents—ideally within weeks.

A Proposer’s Conference and Teaming Connect for the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP will take place virtually on Monday, April 27, 2026 from 11am-12pm EST.

The full RPP, how to register for the Conference, and information on joining the consortium can be accessed through the RRPV website - www.rrpv.org.  

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. April 15, 2026

    Special notice

    Due May 13, 2026 at 1:00 PM EDT. SAM.gov, notice b30c5fc7d9cf4a4cbacb330ea689c84b

    1 revisions on SAM
    • April 15, 2026: publish, special notice

Points of contact